Results from a 36-Week Open-Label Study of Recombinant Human Growth Hormone and Testosterone in Facioscapulohumeral Muscular Dystrophy (FSHD)
Chad Heatwole,Elizabeth Luebbe,Johanna Hamel, Philip Mongiovi,Emma Ciafaloni,Nuran Dilek,William Martens,David Weber, Rashid Hani, Jamie Allen, Claire Smith, Samantha Howell,Spencer Rosero,Katy Eichinger, Linday Baker,Jeanne Dekdebrun, Jim Hilbert,Anika Varma,Michael McDermott,Charles Thornton,Richard Moxley NEUROLOGY（2023）
AI 理解论文
溯源树
样例
